The Complexities of Psychedelic Therapies

This chapter examines the implications of an FDA ruling on a drug for therapeutic use, raising concerns about reporting practices and trial designs. It features personal stories and critiques around the medicalization of psychedelics, addressing issues of misinformation and the ethical dimensions of treatment for PTSD. The discussion highlights the urgent need for accurate reporting and accountability in both clinical trials and underground practices in the psychedelic field.